BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15658457)

  • 1. [2' 5'-oligoadenylate synthetase (2-5AS)].
    Kaneko S; Sakai A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():812-4. PubMed ID: 15658457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of 2-5 oligoadenylate synthetase analysis in blood cell chemical analysis].
    Kato Y; Hattori N
    Nihon Rinsho; 1989 Dec; 48 Suppl():963-6. PubMed ID: 2482910
    [No Abstract]   [Full Text] [Related]  

  • 3. [2-5 Oligoadenylate synthetase].
    Koura T; Kato Y; Unoura M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():202-5. PubMed ID: 8753217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
    Daito K; Suou T; Kawasaki H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV NS5A 2209-2248 amino acid substitutions affect serum 2,5AS activities.
    Murashima S; Kumashiro R; Ide T; Sata M
    J Hepatol; 1999 Aug; 31(2):382. PubMed ID: 10453957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
    Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
    Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum 2-5 oligoadenylate synthetase activity in infectious diseases and collagen diseases in childhood].
    Arai T; Yamamoto H; Sakamoto M; Eda N; Matsumoto T; Ikei K; Hashimoto H; Seki T; Ohtani T; Ohishi T
    Kaku Igaku; 1991 Feb; 28(2):197-203. PubMed ID: 2051656
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 2',5'-oligoadenylate synthetase concentrations in acute and chronic hepatitis C.
    Yang PM; Wang JT; Chiang BL; Lai MY; Chen DS
    J Formos Med Assoc; 1997 May; 96(5):314-9. PubMed ID: 9170817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of serum 2'-5'-oligoadenylate synthetase for early diagnosis of viral infections among febrile adult patients.
    Yanai M; Gon Y; Suzuki K; Hayashi Y; Hasumi S; Otsuka H; Soma M
    Infect Dis (Lond); 2016; 48(5):338-42. PubMed ID: 26624960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells from patients with fulminant hepatitis.
    Nishino S; Ohnishi H; Muto Y; Moriwaki H; Sakai T; Sugihara J; Saitoh K
    Gastroenterol Jpn; 1989 Jun; 24(3):337. PubMed ID: 2744346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differential diagnosis of non-A, non-B hepatitis and drug-induced hepatopathy].
    Kiyosawa K; Yoshizawa K; Sodeyama T; Furuta S
    Nihon Rinsho; 1988 Dec; 46(12):2645-51. PubMed ID: 3149337
    [No Abstract]   [Full Text] [Related]  

  • 14. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
    Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
    Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2'-5' olygoadenylate synthetase activity in peripheral facial paralysis].
    Nakazato H; Ikeda M
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Mar; 98(3):457-64. PubMed ID: 7738709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear leukocytes in Behçet's disease].
    Ohno S; Kotake S; Hirose S; Matsuda H; Fujii N
    Nippon Ganka Gakkai Zasshi; 1986 May; 90(5):771-4. PubMed ID: 2428227
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interferon (IFN)-alpha, beta, gamma].
    Uno K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():89-92. PubMed ID: 16149460
    [No Abstract]   [Full Text] [Related]  

  • 19. 2',5'-Oligoadenylate and 2',5'-oligoadenylate phosphodiesterase in human plasma.
    Sawai H; Ishibashi K; Itoh M; Watanabe S
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1061-6. PubMed ID: 6517934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.
    Sugino H; Mitani I; Koike M; Kodama T; Sokawa J; Sawai H; Ishibashi K; Itoh M; Watanabe S; Sokawa Y
    J Clin Microbiol; 1986 Sep; 24(3):478-81. PubMed ID: 3760142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.